Pine Valley Investments LTD Liability CO Arrowhead Pharmaceuticals, Inc. Transaction History
Pine Valley Investments LTD Liability CO
- $1.67 Trillion
- Q4 2024
A detailed history of Pine Valley Investments LTD Liability CO transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Pine Valley Investments LTD Liability CO holds 19,741 shares of ARWR stock, worth $416,140. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,741
Previous 19,686
0.28%
Holding current value
$416,140
Previous $381 Million
2.67%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding ARWR
# of Institutions
306Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$331 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$257 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$234 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$127 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$110 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.23B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...